ARCHIVES

Early Clinical Trials Of Targeted Therapies Highlighted At AACR-NCI-EORTC Meeting

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

July 26, 2013

Research Opportunities In Pancreas Cancer Described; Top Priority Set

December 21, 1973

In Brief: NCI To Work More Closely With Biotherapeutics, DeVita Says; apportionment May Be Abolished

February 12, 1988

New Predictive Score May Help In Planning Adjuvant Therapy

September 26, 2008

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

May 4, 2012

NCAB To Hear Reports On Environmental Carcinogenesis, International Research Efforts

June 4, 1976